C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
11/2004
11/09/2004	US6815461 Method of inhibiting retroviral integrase
11/04/2004	WO2004093873A1 2-phenyl-benzimidazol and 2-phenyl-imidazo-`4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer
11/04/2004	WO2004067703A3 5ht7 antagonists and inverse agonists
11/04/2004	WO2004050681A3 Kinase modulators
11/04/2004	WO2003087044A3 Novel carboxamide compounds for use in mch receptor related disorders
11/04/2004	US20040220236 4-Aryl quinols and analogs thereof as therapeutic agents
11/04/2004	US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/04/2004	US20040220169 anticoagulants; factor x inhibitor; N-[1-(5-chloro-1H-benzimidazol-2-yl)ethyl]-3-methyl-4-(2,5-dihydropyrrol-1-ylcarbonyl)benzamide
11/04/2004	CA2522562A1 2-phenyl-benzimidazol and 2-phenyl-imidazo-`4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer
11/03/2004	EP1473292A1 Aromatic heterocyclic compounds as anti-inflammatory agents
11/03/2004	EP1472245A2 Heteroaryl compounds useful as inhibitors of gsk-3
11/03/2004	EP1472237A1 Catechol bioisosteres
11/03/2004	EP1472216A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
11/03/2004	EP1472214A2 Compounds for inhibiting insulin secretion and methods related thereto
11/02/2004	CA2115536C Heterocyclically substituted phenyl-cyclohexane-carboxylic acid derivatives
10/2004
10/28/2004	WO2004092346A2 Small molecule inhibition of a pdz-domain interaction
10/28/2004	WO2004092142A1 An improved process for manufacture of substituted benzimidazoles
10/28/2004	WO2004092131A1 Indole derivatives as ppar modulators
10/28/2004	WO2004092115A2 Hydroxamates as therapeutic agents
10/28/2004	WO2004075823A8 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
10/28/2004	WO2004069806A3 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds
10/28/2004	US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal
10/28/2004	US20040214857 Substituted benzimidazoles and imidazo-[4,5]-pyridines
10/28/2004	US20040214841 Quinazoline derivatives for treatment of tumours
10/28/2004	US20040214821 Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
10/28/2004	US20040214107 optical and electro-optical apparatus comprising recording layer consists of organic pigments and stabilizer agents, and reflection layers formed on light transmitting substrates; sensitivity for red light
10/27/2004	EP1470111A1 Method for the production and purification of 1,7'-dimethyl-2'-propyl-2,5'-bi-1 h-benzimidazole
10/27/2004	EP1212269B1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds
10/26/2004	US6809176 Compounds for use in treatment of cancer
10/26/2004	US6809089 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
10/26/2004	CA2196263C Process for the preparation of 4-oxoimidazolinium salts
10/21/2004	WO2004089942A2 Benzimidazolidinone derivatives as muscarinic agents
10/21/2004	WO2004089912A1 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds
10/21/2004	WO2004089366A1 Bicyclic compounds as nr2b receptor antagonists
10/21/2004	WO2004089360A1 Polyamine compounds for treating chemokine receptor mediated diseases
10/21/2004	WO2003096980A3 Bicyclic modulators of androgen receptor function
10/21/2004	US20040209892 Heterocyclic compounds and methods of use
10/21/2004	DE10314702A1 Verfahren zur Herstellung von Telmisartan Process for the preparation of telmisartan
10/21/2004	CA2521907A1 Bicyclic compounds as nr2b receptor antagonists
10/21/2004	CA2521416A1 Polyamine compounds for treating chemokine receptor mediated diseases
10/20/2004	EP1467974A1 Benzimidazole derivatives and their use as gnrh antagonists
10/20/2004	EP1467733A1 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists
10/20/2004	CN1171872C Compounds for modulation of PPAP gamma activity
10/20/2004	CN1171582C Oral pharmaceutical extended release dosage form
10/14/2004	WO2004087690A2 Benzimidazole derivatives and their use for modulating the gaba-a receptor complex
10/14/2004	WO2004087676A1 Method for the production of telmisartan
10/14/2004	WO2004056727A3 Process of making chalcone derivatives
10/14/2004	US20040204412 Useful as anticoagulants in therapy and prophylaxis of cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in therapy of cancer
10/14/2004	US20040204409 Useful as antagonists of NMDA (N-methyl-D-aspartate) NR2B receptor; for therapy of pain, stroke, traumatic brain injury, Parkinson's disease, Alzheimer's disease, depression, anxiety, migraine
10/14/2004	CA2520281A1 Benzimidazole derivatives and their use for modulating the gabaa recept or complex
10/13/2004	EP1466898A1 Beta-amyloid protein production/secretion inhibitors
10/13/2004	EP1466625A1 Preventives/remedies for urinary disturbance
10/13/2004	EP1466603A2 Novel catechols as antimicrobial agents
10/13/2004	EP1465889A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
10/13/2004	EP1465888A2 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
10/13/2004	EP1465874A2 New material for transporting electrons and organic electroluminescent display using the same
10/13/2004	EP1465861A1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
10/13/2004	EP1465854A2 Chalcone derivatives and their use to treat diseases
10/13/2004	EP1465635A2 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues
10/13/2004	EP1465623A1 Urea derivatives
10/13/2004	EP1322309A4 High affinity small molecule c5a receptor modulators
10/13/2004	EP1086086B1 Imidazolyl derivatives and their use as somatostatin receptor ligands
10/13/2004	CN1537112A Pyrimidine compound
10/12/2004	US6803384 Diaminopropionic acid derivatives
10/12/2004	US6803374 Compounds useful for treating hepatitis C virus
10/07/2004	WO2004085425A1 Fused azoles such as 2,5-disubstituted benzimidazoles, benzoxazoles and benzothiazoles as kinase inhibitors
10/07/2004	WO2004075823A3 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
10/07/2004	US20040198791 Fused imidazole derivative
10/07/2004	US20040198733 Obesity; antidiabetic agents; cardiovascular disorders; antilipemic agentsl circadian rhythm disorders; hypotensive agents; antidepressants; anxiolytic agents
10/07/2004	US20040198732 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals
10/07/2004	US20040198731 Antidiabetic agents; cardiovascular disorders; anticholesterol agents; antidepressants; schizophrenia; antilipemic agents; circidian rhythm disorders
10/07/2004	CA2518909A1 Heterocyclic compounds and methods of use
10/06/2004	EP1463714A2 Vanilloid receptor ligands and their use in treatments
10/06/2004	CN1534025A Preparation method of benzimidazole derivative or its salt
10/05/2004	US6800645 Substituted azabicyclic compounds
10/05/2004	CA2282834C Novel hexanoic acid derivatives
10/05/2004	CA2156024C Synthetic excitatory amino acids
09/2004
09/30/2004	WO2004083187A1 Monocyclic anilide spirohydantoin cgrp receptor antagonists
09/30/2004	WO2004082678A1 Aryl spirohydantoin cgrp receptor antagonists
09/30/2004	WO2004082638A2 Histone deacetylase inhibitors
09/30/2004	WO2004082602A2 Carboxamide spirohydantoin cgrp receptor antagonists
09/30/2004	WO2004041209A3 Transcription factor modulating compounds and methods of use thereof
09/30/2004	US20040192748 Heterocyclic compounds
09/30/2004	US20040192713 Novel synthesis of irbesartan
09/30/2004	US20040192693 Antidiabetic agents; arteriosclerosis; cardiovascular disorders; anticholesterol agents; antidepressants; schizophrenia; antilipemic agents
09/30/2004	US20040192681 N-acylsulfonamide apoptosis promoters
09/30/2004	CA2518852A1 Monocyclic anilide spirohydantoin cgrp receptor antagonists
09/30/2004	CA2518843A1 Aryl spirohydantoin cgrp receptor antagonists
09/30/2004	CA2518830A1 Carboxamide spirohydantoin cgrp receptor antagonists
09/30/2004	CA2518318A1 Histone deacetylase inhibitors
09/29/2004	EP1461035A2 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
09/29/2004	EP1461034A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
09/29/2004	EP1189881B1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
09/29/2004	EP1165557B1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS
09/28/2004	US6797731 Resorcinol derivatives
09/28/2004	US6797726 N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same
09/28/2004	US6797717 Acyl coenzyme a cholesterol acyltransferase (acat) inhibitors
09/23/2004	WO2004080975A1 Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same
09/23/2004	WO2004064723A3 Inhibitors and methods of use thereof
09/23/2004	WO2004043913A3 Hetero-substituted benzimidazole compounds and antiviral uses thereof

1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 154